Videos de Experimentos Relacionados
¿Está desapareciendo la esquizofrenia?
1Institute of Psychiatry, Denmark Hill, London.
Lancet (London, England)
|March 3, 1990
Resumen
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies.
Psychological medicine·2019
Same author
Characteristics of a protocol to collect objective physical activity/sedentary behaviour data in a large study: Seniors USP (understanding sedentary patterns).
Journal for the measurement of physical behaviour·2018
Same author
Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.
Schizophrenia research·2018
Same author
Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders.
Schizophrenia research·2018
Same author
Systematic comparative validation of self-report measures of sedentary time against an objective measure of postural sitting (activPAL).
The international journal of behavioral nutrition and physical activity·2018
Same author
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains.
Psychological medicine·2017
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026